VOLTATTORNI, Carla
 Distribuzione geografica
Continente #
NA - Nord America 7.836
EU - Europa 5.777
AS - Asia 4.920
SA - Sud America 535
Continente sconosciuto - Info sul continente non disponibili 120
AF - Africa 83
OC - Oceania 11
Totale 19.282
Nazione #
US - Stati Uniti d'America 7.686
RU - Federazione Russa 2.004
SG - Singapore 1.953
CN - Cina 1.738
GB - Regno Unito 1.627
BR - Brasile 427
HK - Hong Kong 405
IT - Italia 344
FR - Francia 338
SE - Svezia 335
VN - Vietnam 334
FI - Finlandia 308
DE - Germania 307
IE - Irlanda 226
KR - Corea 148
UA - Ucraina 132
CA - Canada 90
IN - India 64
BD - Bangladesh 59
JP - Giappone 58
AR - Argentina 40
MX - Messico 33
TR - Turchia 33
NL - Olanda 26
BE - Belgio 25
ID - Indonesia 23
ZA - Sudafrica 22
IQ - Iraq 21
PL - Polonia 19
EC - Ecuador 18
NG - Nigeria 18
CL - Cile 14
ES - Italia 14
SA - Arabia Saudita 14
UZ - Uzbekistan 12
PK - Pakistan 11
LT - Lituania 10
MA - Marocco 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
AU - Australia 9
CO - Colombia 8
UY - Uruguay 8
VE - Venezuela 8
BG - Bulgaria 7
EG - Egitto 7
JM - Giamaica 7
CH - Svizzera 6
GR - Grecia 6
LV - Lettonia 6
PH - Filippine 6
PY - Paraguay 6
IL - Israele 5
RO - Romania 5
TN - Tunisia 5
CR - Costa Rica 4
KE - Kenya 4
PT - Portogallo 4
AZ - Azerbaigian 3
EU - Europa 3
GA - Gabon 3
JO - Giordania 3
NI - Nicaragua 3
PA - Panama 3
PE - Perù 3
SV - El Salvador 3
TG - Togo 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
GH - Ghana 1
GN - Guinea 1
HN - Honduras 1
HU - Ungheria 1
Totale 19.152
Città #
Southend 1.443
Singapore 1.067
Jacksonville 1.060
Ashburn 817
San Jose 780
Moscow 630
Chandler 621
Woodbridge 565
Dallas 551
Hong Kong 399
Ann Arbor 370
Houston 297
Beijing 236
Dublin 224
Verona 214
The Dalles 188
Council Bluffs 181
Jinan 150
Nanjing 138
Wilmington 131
Lawrence 128
Princeton 128
Shenyang 126
Ho Chi Minh City 119
Los Angeles 109
New York 97
Hanoi 91
Tianjin 77
Sindelfingen 73
Hebei 72
Buffalo 71
Changsha 67
Helsinki 63
Boardman 62
Santa Clara 56
Ningbo 53
Tokyo 52
Columbus 51
Nanchang 51
Haikou 47
Milan 46
São Paulo 45
Zhengzhou 44
Hangzhou 41
Munich 40
Taiyuan 36
Philadelphia 35
Guangzhou 33
Jiaxing 32
San Francisco 32
Taizhou 32
Lanzhou 29
Toronto 29
Montreal 27
Redondo Beach 27
Lancaster 26
Orem 26
Brooklyn 25
Chicago 25
Fuzhou 25
Seattle 22
Brussels 21
Chennai 21
London 21
Norwalk 21
Belo Horizonte 19
Boston 19
Frankfurt am Main 19
Johannesburg 18
Phoenix 18
Seoul 18
Warsaw 18
Falls Church 16
Redmond 16
Abuja 15
Denver 15
Haiphong 14
Stockholm 14
Auburn Hills 12
Detroit 12
Jakarta 12
Mexico City 12
Rio de Janeiro 11
Tashkent 11
Amsterdam 10
Da Nang 10
Manchester 9
Atlanta 8
Clearwater 8
Dearborn 8
Fairfield 8
Kent 8
Quito 8
Riva 8
Shanghai 8
Berlin 7
Can Tho 7
Dhaka 7
Elora 7
Falkenstein 7
Totale 12.833
Nome #
Dimerization and Folding Processes of Treponema denticola Cystalysin: The Role of Pyridoxal 5'-Phosphate 286
Holo-and apocystalysin from Treponema denticola: two different conformations 274
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 264
Pyridoxal 5’-Phosphate Enzymes as Targets for Therapeutic Agents 260
A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanisms to therapy implications 236
Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications 231
Affinity labelling of pig kidney Dopa decarboxylase with N-(bromoacetyl)pyridoxamine 5'-phosphate. Modification of an active site cysteine 227
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 226
Dopa decarboxylase exhibits low pH half-transaminase and high pH oxidative deaminase activities toward serotonin (5-hydroxytryptamine) 210
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 205
Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli 203
An engineered folded PLP-bound monomer of Treponema denticola cystalysin reveals the effect of the dimeric structure on the catalytic properties of the enzyme 202
Folding defects leading to primary hyperoxaluria 202
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 198
A quinonoid is an intermediate of oxidative deamination reaction catalyzed by Dopa decarboxylase 197
Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications 195
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 194
An essential arginine residue at the binding site of pig kidney 3,4-dihydroxyphenylalanine decarboxylase 192
Chemical modification of pig kidney 3,4-dihydroxyphenylalanine decarboxylase with diethyl pyrocarbonate. Evidence for an essential histidyl residue 190
Human liver peroxisomal alanine:glyoxylate aminotransferase: Characterization of the two allelic forms and their pathogenic variants. 190
Cysteine 180 Is a Redox Sensor Modulating the Activity of Human Pyridoxal 5'-Phosphate Histidine Decarboxylase 187
Cystalysin: an example of the catalytic versatility of pyridoxal 5'-phosphate dependent enzymes 184
New variants of AADC deficiency expand the knowledge of enzymatic phenotypes 182
The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase 180
Aromatic amino acid methyl ester analogs form quinonoidal species with Dopa decarboxylase 178
Folding pathway of the pyridoxal 5'-phosphate C-S lyase MalY from Escherichia coli 177
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: Glyoxylate aminotransferase and the F152I mutation 176
Phosphorylation of pyridoxal 5'-phosphate enzymes: an intriguing and neglected topic 175
Behavior of fluorinated analogs of L-(3,4-dihydroxyphenyl)alanine and L-threo-(3,4-dihydroxyphenyl)serine as substrates for Dopa decarboxylase 174
An affinity labeling reagent for pyridoxal phosphate dependent enzymes 171
Alpha5 pyridoxalacetic acid and alpha5 pyridoxyl-L-phenylalanine acetic acid: their action on some B6-dependent enzymes 170
Mutation of residues in the coenzyme binding pocket of Dopa decarboxylase: effects on catalytic properties 165
Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook 164
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: glyoxylate aminotransferase and the f152i mutation 163
New insights emerging from recent investigations on human group II pyridoxal 5'-phosphate Decarboxylases 162
[Preparation and properties of the beta-Hp-Hb complex] 161
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 158
[Binding of pyridoxyl derivatives to apoaspartate transaminase from swine hearts] 157
Deficit of human ornithine aminotransferase in gyrate atrophy: Molecular, cellular, and clinical aspects 157
[Action of pyridoxyl-glutamic acid on transaminases] 156
Identification by Virtual Screening and In Vitro Testing of Human DOPA Decarboxylase Inhibitors 156
[Inhibition of APO-DOPA-decarboxylase by phosphopyridoxyl-amino acids] 155
Dopa decarboxylase: the pig kidney enzyme primary structure and relationship to other amino acid decarboxylases 155
Cloning and expression of pig kidney dopa decarboxylase: comparison of the naturally occurring and recombinant enzymes 154
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 154
Molecular and cellular basis of ornithine δ-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina 154
R180T variant of δ-ornithine aminotransferase associated with gyrate atrophy: biochemical, computational, X-RAY and NMR studies provide insight into its catalytic features 154
Pig kidney dopa decarboxylase: inactivation by iodoacetamide and sequence of the carboxyamidomethylcysteine-containing peptide 153
[Binding of phosphopyridoxyl derivatives to apoaspartate aminotransferase from wheat germ] 153
Site-directed mutagenesis provides insight into racemization of alanine catlayzed by "Treponema denticola" cystalysin 153
An abnormal reaction occurring in the presence of L-aromatic aminoacid decarboxylase 152
[Preliminary studies of apo-tyrosine decarboxylase inhibitors] 151
Crystallization and preliminary X-ray analysis of pig kidney DOPA decarboxylase 151
Thermodynamic parameters for substrate-coenzyme protein complex formation in b6-dependent enzymes 150
Structural and functional aspects of the active site in aspartate aminotransferase 150
Stereospecificity of sodium borohydride reduction of pig kidney dopa decarboxylase 150
[Separation of pyridoxal phosphate dependent enzymes by means of carboxymethylcellulose hydrazide] 149
A new assay for DOPA decarboxylase activity 149
[Interaction of dopa decarboxylase from swine kidney with thiosemicarbazone] 148
Dopa decarboxylase 147
A novel compound heterozygous genotype associated with aromatic amino acid decarboxylase deficiency: Clinical aspects and biochemical studies 146
Spectroscopic and kinetic analyses reveal the pyridoxal 5'-phosphate binding mode and the catalytic features of Treponema denticola cystalysin 145
Biochemical and bioinformatic studies of mutations of residues at the monomer-monomer interface of human ornithine aminotransferase leading to gyrate atrophy of choroid and retina 144
Tyrosine hydroxylase-immunoreactive neurons in the human cerebral cortex: a novel catecholaminergic group? 142
[Effect of Mg++ ion on 5-nucleotidase activity] 141
[Effect of pH on the interaction of 3'-nucleotidase from wheat germ with 5'-phosphate nucleotides] 141
[Study of the inhibition of the 3'-nucleotidase of the wheat germ by 5'-nucleotides] 140
Mutation of cysteine 111 in dopa decarboxylase leads to active site perturbation 139
Insights into the mechanism of oxidative deamination catalyzed by Dopa decarboxylase 139
DISSOCIATION, UNFOLDING AND REFOLDING TRIALS OF PIG KIDNEY 3,4-DIHYDROXYPHENYLALANINE (DOPA) DECARBOXYLASE 138
Heterozygosis in aromatic amino acid decarboxylase deficiency: Evidence for a positive interallelic complementation between R347Q and R358H mutations 138
Lysine 238 is an essential residue for alfa, beta- elimination catalyzed by "Treponema denticola" cystalysin 134
[Preliminary studies on inhibitors of apo-tyrosine transaminase] 133
Dopaminergic and noradrenergic sympathetic nerves of the dog have different DOPA decarboxylase activities 132
Aromatic L-amino acid decarboxylase. Immunoreactive cells in the tuberal of the carboxyamidomethylcysteine 132
Interaction of aromatic amino acids in D and L forms with 3,4-dihydroxyphenylalanine decarboxylase from pig kidney 132
Reactions of DOPA (3,4-dihydroxyphenylalanine) decarboxylase with DOPA 132
Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. 132
Pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase. Primary structure and relationships to other amino acid decarboxylases 131
Probing the role of Tyr 64 of Treponema denticola cystalysin by site-directed mutagenesis and kinetic studies 131
Time-resolved extrinsic fluorescence of aromatic-L-amino-acid decarboxylase 130
Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency. 129
The binding of coenzymes and analogues of the substrate-coenzyme complex to tyrosine aminotransferase 128
The binding of nucleotides to 3'-nucleotidase from wheat germ 127
Purification and characterization of rat-liver 3,4-dihydroxyphenylalanine decarboxylase 127
Mechanism-based inactivation of dopa decarboxylase by serotonin 127
The steady state kinetics of tyrosine decarboxylase from Streptococcus faecalis 126
Dopa decarboxylase 125
The binding of the coenzyme pyridoxal 5'-phosphate and analogues of the substrate-coenzyme complex to tyrosine decarboxylase 124
The use of 4'-N-(2,4-dinitro-5-fluorophenyl)-pyridoxamine 5'-phosphate 124
Reaction specificity of native and nicked 3,4-dihydroxyphenylalanine decarboxylase 124
Pig kidney dopa decarboxylase. Structure and function 123
Treponema denticola cystalysin catalyzes beta-desulfination of L-cysteine sulfinic acid and beta-decarboxylation of L-aspartate and oxalacetate 122
Characterization of DOPA decarboxylase mRNA in rat pheochromocytoma 121
Spectral properties of the coenzyme bound to dopa decarboxylase from pig kidney 119
Treponema denticola cystalysin exhibits a significant alanine racemase activity accompanied by transamination: mechanistic implications 119
Reactions of human liver peroxisomal alanine:glyoxylate aminotransferase with beta-chloro-L-alanine and L-cysteine: spectroscopic and kinetic analysis 119
Interaction of L-alpha-methyl-alpha-hydrazino-3,4 dihydroxyphenylpropionic acid with dopa-decarboxylase from pig kidney 117
Ornithine and glutamate decarboxylases catalyse an oxidative deamination of their alpha-methyl substrates 116
Multiple roles of the active site lysine of Dopa decarboxylase 116
Totale 16.022
Categoria #
all - tutte 63.041
article - articoli 59.736
book - libri 0
conference - conferenze 486
curatela - curatele 0
other - altro 456
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.363
Totale 126.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.107 0 407 129 45 22 20 12 56 39 19 72 286
2022/20231.973 167 154 185 345 212 432 32 122 226 13 59 26
2023/2024776 42 80 62 188 58 76 25 41 3 22 126 53
2024/20252.545 199 152 38 442 124 43 129 121 398 173 234 492
2025/20267.049 569 322 602 965 1.644 456 809 384 621 428 124 125
2026/2027288 91 197 0 0 0 0 0 0 0 0 0 0
Totale 19.282